Enzo Biochem Inc. (NYSE:ENZ)’s share price traded up 3.6% during mid-day trading on Tuesday . The company traded as high as $6.07 and last traded at $6.07, with a volume of 160,522 shares traded. The stock had previously closed at $5.86.

Separately, Zacks Investment Research upgraded shares of Enzo Biochem from a “sell” rating to a “hold” rating in a research note on Tuesday, May 24th.

The stock has a market cap of $282.21 million and a P/E ratio of 15.97. The stock has a 50-day moving average price of $6.38 and a 200 day moving average price of $5.38.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings results on Wednesday, June 8th. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.02. The firm had revenue of $18.16 million for the quarter, compared to analysts’ expectations of $24.50 million. During the same quarter in the prior year, the business posted ($0.07) EPS. On average, equities analysts expect that Enzo Biochem Inc. will post ($0.23) earnings per share for the current year.

Enzo Biochem, Inc (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.